首页 | 本学科首页   官方微博 | 高级检索  
检索        

2型糖尿病视网膜病变合并骨质疏松患者血清25(OH)D与Betatrophin的关系
引用本文:王哲 阳琰,刘贝贝 李琪 樊思桐 王贺.2型糖尿病视网膜病变合并骨质疏松患者血清25(OH)D与Betatrophin的关系[J].中国骨质疏松杂志,2018(9):1148-1153.
作者姓名:王哲 阳琰  刘贝贝 李琪 樊思桐 王贺
作者单位:遵义医学院附属医院内分泌科
基金项目:国家自然科学基金(项目编号:81460168);贵州省科学技术基金项目{编号:黔科合J字LKZ[2013]19号};遵义医学院博士启动基金([2012]F-574)
摘    要:目的探讨2型糖尿病视网膜病变(type 2 diabetes mellitus retinopathy,T2DR)合并骨质疏松(osteoporosis,OP)患者血清25羟维生素D25-hydroxy vitamin D,25(OH)D]与Betatrophin之间的关系。方法选取2016年11月-2017年9月在我院内分泌科就诊的2型糖尿病(Type 2 Diabetes Mellitus,T2DM)患者100例,通过非散瞳眼底检查将T2DM患者分为并发DR组35例和非DR组65例,再据骨密度测定结果将DR组分为合并骨质疏松组(T2DM+DR+OP组)15例及非骨质疏松组(T2DM+DR组)20例,将非DR组分为合并骨质疏松组(T2DM+OP组)25例及非骨质疏松组(T2DM组)40例。同期随机筛选健康体检中心不同年龄健康受试者60例为正常对照(normal control,NC)组。酶联免疫吸附(ELISA)法测定所有受试者血清中Betatrophin水平,电化学发光法测定25(OH)D水平。结果与非骨质疏松的2型糖尿病视网膜病变患者相比,合并骨质疏松的2型糖尿病视网膜病变患者血清25(OH)D水平降低,Betatrophin水平升高,差异具有统计学意义(P0.05)。结论血清中25(OH)D水平降低及Betatrophin水平升高,可能共同参与了2型糖尿病视网膜病变、骨质疏松的发生发展。

关 键 词:2型糖尿病视网膜病变  骨质疏松  25羟维生素D  Betatrophin

Relationship between serum 25(OH)D and Betatrophin in patients with type 2 diabetic mellitus retinopathy combined with osteoporosis
WANG Zhe,YANG Yan,LIU Beibei,LI Qi,FAN Sitong,WANG He.Relationship between serum 25(OH)D and Betatrophin in patients with type 2 diabetic mellitus retinopathy combined with osteoporosis[J].Chinese Journal of Osteoporosis,2018(9):1148-1153.
Authors:WANG Zhe  YANG Yan  LIU Beibei  LI Qi  FAN Sitong  WANG He
Institution:Department of Endocrinology, the First Affiliated Hospital of Zunyi Medical College, Zunyi 563099, China
Abstract:Objective To investigate the relationship between serum 25-hydroxy vitamin D 25(OH)D] and Betatrophin in patients with type 2 diabetic mellitus retinopathy (DR) combined with osteoporosis (OP). Methods One hundred patients with type 2 diabetes mellitus (T2DM) were selected from the Department of Endocrinology in our hospital from November 2016 to September 2017. the T2DM patients were divided into DR group with (35 cases) and non-DR group (65 cases) by non-mydriatic fundus examination. Then according to the bone mineral density measurement results, DR group was divided into OP group (group T2DM+DR+OP, 15 cases) and non-OP group (group T2DM+DR, 20 cases). Non-DR group was divided into patients with OP group (T2DM+OP group, 25 cases) and non-OP group (T2DM group, 40 cases). At the same time, 60 healthy subjects of different ages were randomly selected as normal control (NC) group. Enzyme linked immunosorbent assay (ELISA) was used to determine the serum levels of Betatrophin in all subjects. 25(OH)D levels were determined with electrochemiluminescence. Results Compared with those in DR patients with non-OP, 25 (OH) D levels decreased and Betatrophin level increased in DR patients with OP, and the difference was statistically significant. Conclusion The decrease of serum 25 (OH) D level and the elevation of Betatrophin level may be involved in the development of type 2 diabetic mellitus retinopathy and osteoporosis.
Keywords:type 2 diabetes mellitus retinopathy  osteoporosis  25-hydroxy vitamin D  betatrophin
本文献已被 CNKI 等数据库收录!
点击此处可从《中国骨质疏松杂志》浏览原始摘要信息
点击此处可从《中国骨质疏松杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号